Evaluating a Shared Decision Making Program for Crohn's Disease

Specific Aim: Study the impact of the Crohn's Disease Shared Decision Making Program on
patients' treatment choice, persistence with chosen therapy, decision quality, cost of care,
and outcomes

Hypothesis: The Crohn's Disease Shared Decision Making Program will help patients understand
which treatments are right for them and will lead to a higher acceptance of appropriate
therapy, improved persistence with chosen therapy, lower costs and improved clinical
outcomes. To accomplish this aim, Investigators will perform a randomized controlled trial
to:

1. Determine how the shared decision making program influences patients' choice of therapy

2. Evaluate how the shared decision making program affects persistence with chosen therapy

3. Determine how the shared decision making program affects decision quality

4. Determine how the shared decision making program influences cost of care and clinical
outcomes

Expected Outcome and Impact: Investigators expect that this program will influence patients'
choice of therapy, persistence with their preferred therapy, and lead to improved clinical
outcomes. Investigators believe that this product can be successfully operationalized in the
clinic to establish a new paradigm of how providers can communicate personalized treatment
options to patients across a broad range of diseases.